Discovering a New World Through Treatment

How plasma-derived therapies changed one patient’s life is focus of story from the Plasma Protein Therapeutics Association.

Story

As someone living with a primary immunodeficiency disease, Terry once put a limit on his dreams. Before being diagnosed with common variable immune deficiency (CVID) in his late 20s, Terry suffered repeated infections, including bronchitis and pneumonia.

With the help of medicine derived from plasma proteins, Terry says a world that he hadn’t imagined was opened to him. As proof, the now 60-year-old works pursues a passion for physical activity as a group fitness instructor. See more of Terry’s journey in the video.

 The Plasma Protein Therapeutics Association (PPTA) featured Terry and other patients in a campaign called “How Is Your Day?” The group launched the campaign with the support of CSL Behring and PPTA's other global member companies. Its objectives were to differentiate plasma protein therapies from traditional pharmaceuticals and to showcase the value they provide to individuals with rare and serious conditions.

The campaign offers information about the diseases treated by plasma protein therapeutics and emphasizes the essential role played by plasma donors. By explaining a vast majority of these therapies are derived from plasma, the campaign shows that plasma donors save lives every day. Looking ahead to 2020 and beyond, the PPTA plans to expand the campaign's outreach. Learn more by following the campaign's Facebook and Twitter accounts.